English中文
将人工智能用起来
2019年6月18-21日
北京,中国
Yue Cathy Chang

Yue Cathy Chang
Partner, TutumGene

Website | @yuec

Yue “Cathy” Chang is a partner at TutumGene, a technology company that aims to accelerate disease curing by providing solutions for gene therapy and regulation of gene expression. She’s a business executive recognized for sales, business development, and product marketing in high technology. Previously, she was with Silicon Valley Data Science, a startup (acquired by Apple) that provided business transformation consulting to enterprises and other organizations using data science- and engineering-based solutions; employee #1 hired by the CEO at venture-funded software startup Rocana (acquired by Splunk), where she served as senior director of business development focusing on building and growing long-term relationships, and notably increased sales leads 2x through building and managing indirect revenue channels; held multiple strategic roles at blue chip software enterprise companies as well as startups, including corporate and business development at Feedzai and Datameer; senior product management, product marketing and sales at Symantec and IBM; and strategic sourcing improvement consulting at Honeywell. Cathy holds MS and BS degrees in electrical and computer engineering from Carnegie Mellon University, MBA and MS degrees as a leaders for global operations (LGO) duel-degree fellow from MIT, and two patents for her early work in microprocessor logic design.

Sessions

13:1013:50 Friday, June 21, 2019
Yue Cathy Chang (TutumGene)
Genome editing has been dubbed a top technology that could create trillion-dollar markets. Learn how recent advancements in the application of AI to genomic editing are accelerating transformation of medicine with Yue Cathy Chang as she explores how AI is applied to genome sequencing and editing, the potential to correct mutations, and questions on using genome editing to optimize human health. 了解更多信息.